Formulary Chapter 1: Gastro-intestinal system - Full Chapter
01.07
Local preparations for anal and rectal disorders
Anusol® (Cream, Suppository)
Formulary
Anusol® - other brands also available
Benzyl benzoate with bismuth oxide, bismuth subgallate, hydrocortisone acetate, peru balsam and zinc oxide
Formulary
Hydrocortisone with lidocaine
Formulary
01.07.01
Soothing haemorrhoidal preparations
Haemorrhoid relief ointment
Formulary
Haemorrhoid relief suppositories
Formulary
01.07.02
Compound haemorrhoidal preparations with corticosteroids
Scheriproct® (Ointment, Suppository)
First Choice
Uniroid HC® (Ointment. Suppository)
Second Choice
Contains the same ingredients as Proctosedyl® but is much more cost effective
Anusol-HC® (Ointment, Suppository)
Formulary
01.07.03
Rectal sclerosants
Phenol
Formulary
01.07.04
Management of anal fissures
Glyceryl Trinitrate 0.4% Ointment (Rectogesic®)
First Choice
Diltiazem Cream 2% (Anoheal)
Second Choice
£££££
Unlicensed - for use only in patients intolerant of or unresponsive to GTN ointment
Store in the fridge
One tube will last a month if used as 2cm apllication TWICE DAILY
Topical diltiazem 2% may be used twice daily [unlicensed indication] in patients with chronic anal fissures unresponsive or intolerant to topical nitrates and before considering surgery
Cinchocaine hydrochloride with fluocortolone caproate and fluocortolone pivalate
Non Formulary
Cinchocaine with hydrocortisone
Non Formulary
Cinchocaine with prednisolone
Non Formulary
Lidocaine 5% ointment
Non Formulary
Oily phenol injection BP
Non Formulary
Perinal
Non Formulary
Proctofoam HC
Non Formulary
Proctosedyl
Non Formulary
Ultraproct
Non Formulary
Xyloproct®
Non Formulary
Key
Restricted Drug
Unlicensed
Link to adult BNF
Link to children's BNF
Link to SPCs
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
ICB
Low carbon footprint
Medium carbon footprint
High carbon footprint
Status
Description
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist.
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.
